Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Imuvert can prevent some chemotherapy-induced hair loss.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

The treatment was ineffective in humans.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

The drug combination was safe and showed promise in treating advanced tumors.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

A three-year-old girl survived a rare serious infection caused by BCG vaccination, which improved after treatment with a leprosy drug.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Multiomics is revolutionizing biology by enabling breakthroughs in research and disease diagnosis.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

VYC-12L effectively improves skin smoothness, reduces fine lines, and boosts hydration.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

The Labrador dog fully recovered from hypothyroidism after 3 months of treatment.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.